ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BCDA BioCardia Inc

0.4034
0.0334 (9.03%)
After Hours
Last Updated: 07:34:01
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
BioCardia Inc BCDA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0334 9.03% 0.4034 07:34:01
Open Price Low Price High Price Close Price Previous Close
0.37 0.37 0.40 0.3871 0.37
more quote information »

Recent News

Date Time Source Heading
25/4/202423:00GLOBEBioCardia Completes Enrollment of CardiAMP Cell Therapy for..
28/3/202407:00GLOBEBioCardia Reports Fourth Quarter and Full Year 2023 Business..
20/3/202422:00GLOBEBioCardia to Host 2023 Financial Results and Corporate..
13/3/202422:00GLOBEBioCardia and StemCardia Announce Biotherapeutic Delivery..
12/3/202422:00GLOBEBioCardia Announces CMS Approval of Coverage for CardiAMP..
05/3/202400:00EDGAR2Form 8-K - Current report
05/3/202400:00GLOBEBioCardia Reports Positive Interim Results from Phase III..
28/2/202408:53EDGAR2Form SC 13D/A - General statement of acquisition of..
15/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202409:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202408:17EDGAR2Form S-3 - Registration statement under Securities Act of..
10/2/202401:58EDGAR2Form 8-K - Current report
08/2/202423:03EDGAR2Form 8-K - Current report
08/2/202423:00GLOBEBioCardia Announces Activation of CardiAMP Heart Failure II..
07/2/202408:28EDGAR2Form SC 13D/A - General statement of acquisition of..
03/2/202406:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202423:00EDGAR2Form 8-K - Current report
31/1/202423:00GLOBEBioCardia Announces Two Scientific Abstracts Have Been..
03/1/202423:00EDGAR2Form 8-K - Current report
03/1/202423:00GLOBEBioCardia Biotherapeutic Delivery and Morph Access..
19/12/202323:00EDGAR2Form 8-K - Current report
19/12/202323:00GLOBEBioCardia Doses First Patient in CardiALLO Phase I/II..
18/12/202323:16GLOBEBioCardia Announces Expected CardiAMP Heart Failure Japan..
18/12/202323:00EDGAR2Form 8-K - Current report
06/12/202322:05EDGAR2Form 8-K - Current report
06/12/202322:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
06/12/202308:11EDGAR2Form 8-K/A - Current report: [Amend]
06/12/202308:05EDGAR2Form 8-K - Current report
29/11/202323:00EDGAR2Form 8-K - Current report
29/11/202323:00GLOBEBioCardia Shares Update from Japan PMDA Consultation on..
18/11/202309:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/11/202309:15EDGAR2Form 8-K - Current report
17/11/202304:56GLOBEBioCardia Announces $1.3 Million Registered Direct Offering..
14/11/202323:15GLOBEBioCardia Announces FDA Approval of CardiAMP Heart Failure..
09/11/202308:11GLOBEBioCardia Reports Third Quarter 2023 Business Highlights and..
09/11/202308:08EDGAR2Form 8-K - Current report
09/11/202308:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202308:04GLOBEBioCardia to Host Q3 2023 Corporate Update and Financial..
21/10/202300:26EDGAR2Form S-3 - Registration statement under Securities Act of..
20/10/202308:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202308:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202308:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202308:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202308:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202308:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202308:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/10/202307:30EDGAR2Form 8-K - Current report
11/10/202321:04EDGAR2Form 8-K - Current report
11/10/202321:00GLOBEBioCardia Announces Completion of Enrollment in Phase III..

Your Recent History

Delayed Upgrade Clock